Visszatérés

Szolgáltatásink az alábbi országokban elérhetőek

Corporate

Európa:

Zászló Albánia Albánia Zászló Bosznia Herzegovina Bosznia Herzegovina Zászló Bulgária Bulgária Zászló Horvátország Horvátország Zászló Ciprus Ciprus Zászló Montenegró Montenegró Zászló Cseh Köztársaság Cseh Köztársaság Zászló Dánia Dánia Zászló Észtország Észtország Zászló Spanyolország Spanyolország Zászló Koszovó Koszovó Zászló Litvánia Litvánia Zászló Lettország Lettország Zászló Luxemburg Luxemburg Zászló Macedónia Macedónia Zászló Németország Németország Zászló Lengyelország  Lengyelország  Zászló Portugália Portugália Zászló Románia Románia Zászló Szerbia Szerbia Zászló Szlovákia Szlovákia Zászló Szlovénia Szlovénia Zászló Svájc Svájc Zászló Svédország Svédország Zászló Törökország Törökország Zászló Magyarország Magyarország Zászló Egyesült Királyság Egyesült Királyság Zászló Olaszország Olaszország

Ázsia:

Zászló UAE UAE Zászló Hong-Kong Hong-Kong Zászló Kuvait Kuvait Zászló Libanon Libanon

Afrika:

Zászló Dél-Afrika Dél-Afrika
Visszahívást kérek

Szeretne többet megtudni szolgáltasainkról?

Töltse ki az alábbi regisztrációs felületet és kollégáink hamarosan felveszik önnel a kapcsolatot, hogy válaszoljanak minden felmerülő kérdésére

    "Adatait semmilyen körülmények között nem tesszük harmadik fél számára hozzáférhetővé.

    Obraz

    Életmentő
    transzplantációk listája

    A Famicord csoport laboratóriumaiból kezelésre kiadott minták listája.

    Obraz
    Lp. Őssejt forrás Forrás típusa Diagnózis Érintett szakterület Kezelés éve Terápia Ország Páciens életkora
    1001 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 65
    1002 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 61
    1003 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 65
    1004 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 19
    1005 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 65
    1006 Apheresis Allogeneic Mixed Phenotype Acute Leukemia Hematology 2025 Standard Therapy Poland 47
    1007 Apheresis Allogeneic Polycythemia Vera Hematology 2025 Standard Therapy Poland 61
    1008 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 56
    1009 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 53
    1010 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 55
    1011 Apheresis Allogeneic Myelodysplastic Syndrome, Myeloproliferative Neoplasms Hematology 2025 Standard Therapy Poland 34
    1012 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 50
    1013 Apheresis Allogeneic Myelodysplastic Disorders Hematology 2025 Standard Therapy Poland 71
    1014 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2025 Standard Therapy Poland 64
    1015 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 54
    1016 Apheresis Autologous Non-Hodgkin lymphoma Hematology 2025 Standard Therapy Germany 50
    1017 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 50
    1018 Apheresis Allogeneic Acute myeloid leukemia Hematology 2025 Standard Therapy Germany 35
    1019 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 54
    1020 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 52
    1021 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 61
    1022 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 55
    1023 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 64
    1024 Apheresis Autologous Central Nervous System Lymphoma Hematology 2025 Standard Therapy Germany 68
    1025 Apheresis Allogeneic Primary myelofibrosis Hematology 2025 Standard Therapy Germany 71
    1026 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 47
    1027 Apheresis Autologous Central Nervous System Lymphoma Hematology 2025 Standard Therapy Germany 58
    1028 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 68
    1029 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Portugal 44
    1030 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Portugal 59
    1031 Apheresis Autologous Lymphoma Non-Hodgkin Hematology 2025 Standard Therapy Portugal 58
    1032 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Sweden 59
    1033 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 2
    1034 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 41
    1035 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy France 48
    1036 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Sweden 64
    1037 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy United Kingdom 63
    1038 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 64
    1039 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 58
    1040 Apheresis Allogeneic Myelodysplastic Syndrome, Myeloproliferative Neoplasms Hematology 2025 Standard Therapy Poland 68
    1041 Apheresis Allogeneic Myelodysplastic Syndrome, Myeloproliferative Neoplasms Hematology 2025 Standard Therapy Germany 59
    1042 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 56
    1043 Apheresis Allogeneic Diffuse Large B-cell Lymphoma Hematology 2025 Standard Therapy Belarus 53
    1044 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 60
    1045 Apheresis Allogeneic Immunodeficiency – LRBA Hematology 2025 Standard Therapy Turkey 14
    1046 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy Poland 20
    1047 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 65
    1048 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Ukraine 54
    1049 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 75
    1050 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 58
    1051 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 48
    1052 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 37
    1053 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Chile 40
    1054 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 72
    1055 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Switzerland 65
    1056 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2025 Standard Therapy Portugal 68
    1057 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Estonia 9
    1058 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2025 Standard Therapy USA 63
    1059 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Sweden 67
    1060 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Lithuania 45
    1061 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 59
    1062 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 69
    1063 Apheresis Autologous T-cell lymphoma Hematology 2025 Standard Therapy Germany 64
    1064 Apheresis Allogeneic Acute lymphoblastic leukemia Hematology 2025 Standard Therapy Germany 42
    1065 Apheresis Autologous Primary central nervous system lymphoma Hematology 2025 Standard Therapy Germany 64
    1066 Apheresis Allogeneic Myelodysplastic Syndrome/ Acute Myeloid Leukemia Hematology 2025 Standard Therapy Germany 62
    1067 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 42
    1068 Apheresis Autologous T-cell lymphoma Hematology 2025 Standard Therapy Germany 55
    1069 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 72
    1070 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 58
    1071 Apheresis Autologous Central nervous system lymphoma Hematology 2025 Standard Therapy Germany 65
    1072 Apheresis Autologous Follicular lymphoma Hematology 2025 Standard Therapy Germany 67
    1073 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 70
    1074 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 60
    1075 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Portugal 64
    1076 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Portugal 63
    1077 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 67
    1078 Apheresis Autologous Acute myeloid leukemia Hematology 2025 Standard Therapy Germany 60
    1079 Apheresis Autologous Hodgkin lymphoma rezidiv Hematology 2025 Standard Therapy Germany 65
    1080 Apheresis Autologous Non-Hodgkin lymphoma Hematology 2025 Standard Therapy Germany 64
    1081 Apheresis Autologous T-cell lymphoma Hematology 2025 Standard Therapy Germany 67
    1082 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 70
    1083 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 62
    1084 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 62
    1085 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 66
    1086 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 55
    1087 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 60
    1088 Apheresis Allogeneic Fanconi’s Anemia Hematology 2025 Standard Therapy Ukraine 6
    1089 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 69
    1090 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Lithuania 54
    1091 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Macedonia 56
    1092 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy CROATIA 64
    1093 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 75
    1094 Apheresis Allogeneic T-cell Lymphoma Hematology 2025 Standard Therapy NETHERLANDS 65
    1095 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 65
    1096 Apheresis Allogeneic Myeloid Sarcoma Hematology 2025 Standard Therapy Brazil 48
    1097 Apheresis Allogeneic T-cell Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 17
    1098 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy United Kingdom 13
    1099 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2025 Standard Therapy USA 69
    1100 Apheresis Allogeneic T-cell Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 13